(Alliance News) - Creo Medical Group PLC on Tuesday said it has received the first commercial orders for its Speedboat medical device.Shares in Creo were up 12% at 187.24 pence in afternoon Read More
LONDON (Alliance News) - Creo Medical Group PLC on Friday said its loss close to doubled in the 18 months to the end of 2018 on higher administrative expenses, as it worked to develop its surgical Read More
LONDON (Alliance News) - Creo Medical Group PLC on Thursday said the total number of doctors trained in the use of its Speedboat surgical endoscopy device in the US has risen to six.The for Read More
LONDON (Alliance News) - Creo Medical Group PLC on Wednesday said the first patient in the US was treated using the Speedboat device powered by the company's CROMA electrosurgery advanced is a Read More
LONDON (Alliance News) - Creo Medical Group PLC on Monday said the first patient in continental Europe was treated using its Speedboat device.Speedboat is an electrosurgical platform that a Read More
LONDON (Alliance News) - Creo Medical Group PLC said Wednesday it has entered into two framework distribution agreements to provide clinical training and market seeding in Spain and the Benelux is Read More
LONDON (Alliance News) - Creo Medical Group PLC said Friday that Chief Executive Officer Craig Gulliford and Chief Technology Officer Chris Hancock both sold 480,000 shares in the Gulliford and at Read More
LONDON (Alliance News) - Creo Medical Group PLC said Monday it is considering its future funding and has instructed advisers to commence work on a proposed share placing.Initially the to it Read More
LONDON (Alliance News) - Medical device firm Creo Medical Group PLC said Tuesday its half-year loss widened amid higher administrative costs as it expects full commercial of a Read More
